Eaat2 as a therapeutic research target in alzheimer’s disease: a systematic review

HIGHLIGHTS

  • who: Andrea Kwakowsky from the Chongqing University, China have published the research work: EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review, in the Journal: (JOURNAL)
  • what: The inclusion criteria for this review were any EAAT2 study relevant to AD, including humanderived cultured cells, even those where EAAT2 may not have necessarily been the main focus of the study.

SUMMARY

    Alzheimer's disease (AD) is a progressive neurodegenerative condition that is the most common form of dementia, causing impairments in memory and cognitive function (Revi, 2020). Overall . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?